Phase II study of front line therapy with nivolumab and salvage nivolumab + ipilimumab in patients with advanced renal cell carcinoma

Type of Cancer
Genito-Urinary

Phase

Division (Location)

Study ID

NCT#

Brief Description
Phase II study of front line therapy with nivolumab and salvage nivolumab + ipilimumab in patients with advanced renal cell carcinoma

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.